nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—ABCG2—Zafirlukast—asthma	0.0502	0.0836	CbGbCtD
Dabrafenib—CYP2C8—Salmeterol—asthma	0.0341	0.0568	CbGbCtD
Dabrafenib—CYP2C8—Mometasone—asthma	0.0341	0.0568	CbGbCtD
Dabrafenib—ABCB1—Fluticasone furoate—asthma	0.0304	0.0507	CbGbCtD
Dabrafenib—CYP2C8—Zafirlukast—asthma	0.0267	0.0445	CbGbCtD
Dabrafenib—ABCB1—Indacaterol—asthma	0.0248	0.0413	CbGbCtD
Dabrafenib—CYP2C8—Theophylline—asthma	0.0206	0.0344	CbGbCtD
Dabrafenib—ABCG2—Hydrocortisone—asthma	0.0204	0.034	CbGbCtD
Dabrafenib—CYP2C8—Montelukast—asthma	0.0196	0.0326	CbGbCtD
Dabrafenib—CYP2C8—Loratadine—asthma	0.0196	0.0326	CbGbCtD
Dabrafenib—CYP3A4—Fluticasone furoate—asthma	0.0182	0.0304	CbGbCtD
Dabrafenib—CYP3A4—Budesonide—asthma	0.0162	0.0271	CbGbCtD
Dabrafenib—CYP3A4—Indacaterol—asthma	0.0149	0.0248	CbGbCtD
Dabrafenib—CYP3A4—Ciclesonide—asthma	0.0149	0.0248	CbGbCtD
Dabrafenib—CYP3A4—Salbutamol—asthma	0.0138	0.023	CbGbCtD
Dabrafenib—CYP3A4—Flunisolide—asthma	0.0138	0.023	CbGbCtD
Dabrafenib—CYP3A4—Salmeterol—asthma	0.0138	0.023	CbGbCtD
Dabrafenib—ABCB1—Loratadine—asthma	0.0132	0.0221	CbGbCtD
Dabrafenib—ABCG2—Dexamethasone—asthma	0.0127	0.0212	CbGbCtD
Dabrafenib—CYP3A4—Zileuton—asthma	0.0123	0.0205	CbGbCtD
Dabrafenib—CYP3A4—Ipratropium bromide—asthma	0.0123	0.0205	CbGbCtD
Dabrafenib—ABCB1—Methylprednisolone—asthma	0.0121	0.0202	CbGbCtD
Dabrafenib—CYP3A4—Fluticasone Propionate—asthma	0.0117	0.0196	CbGbCtD
Dabrafenib—CYP2C8—Hydrocortisone—asthma	0.0109	0.0181	CbGbCtD
Dabrafenib—CYP3A4—Zafirlukast—asthma	0.0108	0.0181	CbGbCtD
Dabrafenib—CYP3A4—Tiotropium—asthma	0.00933	0.0155	CbGbCtD
Dabrafenib—CYP3A4—Aminophylline—asthma	0.0089	0.0148	CbGbCtD
Dabrafenib—CYP3A4—Theophylline—asthma	0.00837	0.0139	CbGbCtD
Dabrafenib—CYP3A4—Montelukast—asthma	0.00793	0.0132	CbGbCtD
Dabrafenib—CYP3A4—Loratadine—asthma	0.00793	0.0132	CbGbCtD
Dabrafenib—ABCB1—Betamethasone—asthma	0.00787	0.0131	CbGbCtD
Dabrafenib—ABCB1—Prednisolone—asthma	0.00777	0.0129	CbGbCtD
Dabrafenib—ABCB1—Hydrocortisone—asthma	0.00736	0.0123	CbGbCtD
Dabrafenib—ABCB1—Prednisone—asthma	0.00734	0.0122	CbGbCtD
Dabrafenib—CYP3A4—Methylprednisolone—asthma	0.00726	0.0121	CbGbCtD
Dabrafenib—CYP2C8—Dexamethasone—asthma	0.00677	0.0113	CbGbCtD
Dabrafenib—CYP3A4—Triamcinolone—asthma	0.0055	0.00916	CbGbCtD
Dabrafenib—CYP3A4—Betamethasone—asthma	0.00472	0.00786	CbGbCtD
Dabrafenib—CYP3A4—Prednisolone—asthma	0.00465	0.00776	CbGbCtD
Dabrafenib—ABCB1—Dexamethasone—asthma	0.00458	0.00763	CbGbCtD
Dabrafenib—CYP3A4—Hydrocortisone—asthma	0.00441	0.00735	CbGbCtD
Dabrafenib—CYP3A4—Prednisone—asthma	0.0044	0.00733	CbGbCtD
Dabrafenib—NEK11—adrenal gland—asthma	0.00384	0.101	CbGeAlD
Dabrafenib—NEK11—lung—asthma	0.00337	0.0888	CbGeAlD
Dabrafenib—LIMK1—adrenal gland—asthma	0.00275	0.0725	CbGeAlD
Dabrafenib—CYP3A4—Dexamethasone—asthma	0.00274	0.00457	CbGbCtD
Dabrafenib—SIK1—respiratory system—asthma	0.00235	0.0619	CbGeAlD
Dabrafenib—SIK1—bronchus—asthma	0.00193	0.051	CbGeAlD
Dabrafenib—RAF1—respiratory system—asthma	0.00187	0.0493	CbGeAlD
Dabrafenib—BRAF—adrenal gland—asthma	0.0017	0.0448	CbGeAlD
Dabrafenib—RAF1—adrenal cortex—asthma	0.00157	0.0414	CbGeAlD
Dabrafenib—RAF1—epithelium—asthma	0.00156	0.0412	CbGeAlD
Dabrafenib—RAF1—bronchus—asthma	0.00154	0.0406	CbGeAlD
Dabrafenib—RAF1—smooth muscle tissue—asthma	0.0015	0.0397	CbGeAlD
Dabrafenib—BRAF—lung—asthma	0.00149	0.0393	CbGeAlD
Dabrafenib—RAF1—cardiovascular system—asthma	0.00143	0.0377	CbGeAlD
Dabrafenib—SIK1—adrenal gland—asthma	0.00142	0.0375	CbGeAlD
Dabrafenib—RAF1—trachea—asthma	0.00138	0.0364	CbGeAlD
Dabrafenib—SLCO1B3—lung—asthma	0.00128	0.0339	CbGeAlD
Dabrafenib—SIK1—lung—asthma	0.00125	0.0329	CbGeAlD
Dabrafenib—RAF1—adrenal gland—asthma	0.00113	0.0299	CbGeAlD
Dabrafenib—RAF1—lung—asthma	0.000992	0.0262	CbGeAlD
Dabrafenib—ABCG2—adrenal cortex—asthma	0.000648	0.0171	CbGeAlD
Dabrafenib—ABCG2—adrenal gland—asthma	0.000468	0.0124	CbGeAlD
Dabrafenib—ABCG2—lung—asthma	0.00041	0.0108	CbGeAlD
Dabrafenib—ABCB1—respiratory system—asthma	0.000381	0.0101	CbGeAlD
Dabrafenib—ABCB1—adrenal cortex—asthma	0.00032	0.00844	CbGeAlD
Dabrafenib—ABCB1—epithelium—asthma	0.000318	0.0084	CbGeAlD
Dabrafenib—ABCB1—cardiovascular system—asthma	0.000292	0.0077	CbGeAlD
Dabrafenib—ABCB1—trachea—asthma	0.000281	0.00743	CbGeAlD
Dabrafenib—ABCB1—adrenal gland—asthma	0.000231	0.00609	CbGeAlD
Dabrafenib—ABCB1—lung—asthma	0.000202	0.00534	CbGeAlD
Dabrafenib—Arrhythmia—Prednisolone—asthma	9.59e-05	0.000415	CcSEcCtD
Dabrafenib—Pancreatitis—Prednisone—asthma	9.56e-05	0.000413	CcSEcCtD
Dabrafenib—Asthenia—Salbutamol—asthma	9.54e-05	0.000413	CcSEcCtD
Dabrafenib—Vomiting—Mometasone—asthma	9.54e-05	0.000413	CcSEcCtD
Dabrafenib—Hypersensitivity—Budesonide—asthma	9.49e-05	0.00041	CcSEcCtD
Dabrafenib—Immune system disorder—Hydrocortisone—asthma	9.47e-05	0.00041	CcSEcCtD
Dabrafenib—Rash—Mometasone—asthma	9.46e-05	0.000409	CcSEcCtD
Dabrafenib—Dermatitis—Mometasone—asthma	9.45e-05	0.000409	CcSEcCtD
Dabrafenib—Diarrhoea—Montelukast—asthma	9.44e-05	0.000408	CcSEcCtD
Dabrafenib—Pruritus—Salbutamol—asthma	9.41e-05	0.000407	CcSEcCtD
Dabrafenib—Headache—Mometasone—asthma	9.4e-05	0.000406	CcSEcCtD
Dabrafenib—Arrhythmia—Hydrocortisone—asthma	9.37e-05	0.000405	CcSEcCtD
Dabrafenib—Erythema—Prednisolone—asthma	9.35e-05	0.000404	CcSEcCtD
Dabrafenib—Dizziness—Arformoterol—asthma	9.32e-05	0.000403	CcSEcCtD
Dabrafenib—Dizziness—Formoterol—asthma	9.32e-05	0.000403	CcSEcCtD
Dabrafenib—Asthenia—Budesonide—asthma	9.24e-05	0.0004	CcSEcCtD
Dabrafenib—Eye disorder—Methylprednisolone—asthma	9.21e-05	0.000398	CcSEcCtD
Dabrafenib—Mental disorder—Hydrocortisone—asthma	9.19e-05	0.000397	CcSEcCtD
Dabrafenib—Erythema—Hydrocortisone—asthma	9.13e-05	0.000395	CcSEcCtD
Dabrafenib—Malnutrition—Hydrocortisone—asthma	9.13e-05	0.000395	CcSEcCtD
Dabrafenib—Dizziness—Montelukast—asthma	9.12e-05	0.000395	CcSEcCtD
Dabrafenib—Neutropenia—Prednisone—asthma	9.12e-05	0.000394	CcSEcCtD
Dabrafenib—Pruritus—Budesonide—asthma	9.12e-05	0.000394	CcSEcCtD
Dabrafenib—Diarrhoea—Salbutamol—asthma	9.1e-05	0.000394	CcSEcCtD
Dabrafenib—Haemoglobin—Dexamethasone—asthma	9.01e-05	0.000389	CcSEcCtD
Dabrafenib—Haemoglobin—Betamethasone—asthma	9.01e-05	0.000389	CcSEcCtD
Dabrafenib—Haemorrhage—Betamethasone—asthma	8.96e-05	0.000387	CcSEcCtD
Dabrafenib—Haemorrhage—Dexamethasone—asthma	8.96e-05	0.000387	CcSEcCtD
Dabrafenib—Vomiting—Arformoterol—asthma	8.96e-05	0.000387	CcSEcCtD
Dabrafenib—Vomiting—Formoterol—asthma	8.96e-05	0.000387	CcSEcCtD
Dabrafenib—Angiopathy—Methylprednisolone—asthma	8.94e-05	0.000387	CcSEcCtD
Dabrafenib—Nausea—Mometasone—asthma	8.91e-05	0.000385	CcSEcCtD
Dabrafenib—Immune system disorder—Methylprednisolone—asthma	8.9e-05	0.000385	CcSEcCtD
Dabrafenib—Rash—Arformoterol—asthma	8.88e-05	0.000384	CcSEcCtD
Dabrafenib—Rash—Formoterol—asthma	8.88e-05	0.000384	CcSEcCtD
Dabrafenib—Mediastinal disorder—Methylprednisolone—asthma	8.88e-05	0.000384	CcSEcCtD
Dabrafenib—Dermatitis—Arformoterol—asthma	8.87e-05	0.000384	CcSEcCtD
Dabrafenib—Dermatitis—Formoterol—asthma	8.87e-05	0.000384	CcSEcCtD
Dabrafenib—Headache—Formoterol—asthma	8.83e-05	0.000382	CcSEcCtD
Dabrafenib—Headache—Arformoterol—asthma	8.83e-05	0.000382	CcSEcCtD
Dabrafenib—Arrhythmia—Triamcinolone—asthma	8.82e-05	0.000381	CcSEcCtD
Dabrafenib—Diarrhoea—Budesonide—asthma	8.82e-05	0.000381	CcSEcCtD
Dabrafenib—Vision blurred—Prednisolone—asthma	8.81e-05	0.000381	CcSEcCtD
Dabrafenib—Arrhythmia—Methylprednisolone—asthma	8.8e-05	0.000381	CcSEcCtD
Dabrafenib—Dizziness—Salbutamol—asthma	8.8e-05	0.00038	CcSEcCtD
Dabrafenib—Hyperglycaemia—Prednisone—asthma	8.79e-05	0.00038	CcSEcCtD
Dabrafenib—Vomiting—Montelukast—asthma	8.77e-05	0.000379	CcSEcCtD
Dabrafenib—Rash—Montelukast—asthma	8.7e-05	0.000376	CcSEcCtD
Dabrafenib—Dermatitis—Montelukast—asthma	8.69e-05	0.000376	CcSEcCtD
Dabrafenib—Headache—Montelukast—asthma	8.64e-05	0.000374	CcSEcCtD
Dabrafenib—Mental disorder—Methylprednisolone—asthma	8.63e-05	0.000373	CcSEcCtD
Dabrafenib—Erythema—Triamcinolone—asthma	8.6e-05	0.000372	CcSEcCtD
Dabrafenib—Malnutrition—Methylprednisolone—asthma	8.58e-05	0.000371	CcSEcCtD
Dabrafenib—Erythema—Methylprednisolone—asthma	8.58e-05	0.000371	CcSEcCtD
Dabrafenib—Dizziness—Budesonide—asthma	8.52e-05	0.000368	CcSEcCtD
Dabrafenib—Vomiting—Salbutamol—asthma	8.46e-05	0.000366	CcSEcCtD
Dabrafenib—Rash—Salbutamol—asthma	8.39e-05	0.000363	CcSEcCtD
Dabrafenib—Dermatitis—Salbutamol—asthma	8.38e-05	0.000362	CcSEcCtD
Dabrafenib—Eye disorder—Dexamethasone—asthma	8.37e-05	0.000362	CcSEcCtD
Dabrafenib—Eye disorder—Betamethasone—asthma	8.37e-05	0.000362	CcSEcCtD
Dabrafenib—Nausea—Formoterol—asthma	8.37e-05	0.000362	CcSEcCtD
Dabrafenib—Nausea—Arformoterol—asthma	8.37e-05	0.000362	CcSEcCtD
Dabrafenib—Headache—Salbutamol—asthma	8.33e-05	0.00036	CcSEcCtD
Dabrafenib—Back pain—Triamcinolone—asthma	8.32e-05	0.00036	CcSEcCtD
Dabrafenib—Nausea—Montelukast—asthma	8.2e-05	0.000354	CcSEcCtD
Dabrafenib—Vomiting—Budesonide—asthma	8.19e-05	0.000354	CcSEcCtD
Dabrafenib—Angiopathy—Dexamethasone—asthma	8.13e-05	0.000351	CcSEcCtD
Dabrafenib—Angiopathy—Betamethasone—asthma	8.13e-05	0.000351	CcSEcCtD
Dabrafenib—Rash—Budesonide—asthma	8.12e-05	0.000351	CcSEcCtD
Dabrafenib—Dermatitis—Budesonide—asthma	8.12e-05	0.000351	CcSEcCtD
Dabrafenib—Headache—Budesonide—asthma	8.07e-05	0.000349	CcSEcCtD
Dabrafenib—Hypertension—Prednisolone—asthma	8.07e-05	0.000349	CcSEcCtD
Dabrafenib—Arrhythmia—Dexamethasone—asthma	8e-05	0.000346	CcSEcCtD
Dabrafenib—Arrhythmia—Betamethasone—asthma	8e-05	0.000346	CcSEcCtD
Dabrafenib—Alopecia—Dexamethasone—asthma	7.92e-05	0.000342	CcSEcCtD
Dabrafenib—Alopecia—Betamethasone—asthma	7.92e-05	0.000342	CcSEcCtD
Dabrafenib—Nausea—Salbutamol—asthma	7.9e-05	0.000342	CcSEcCtD
Dabrafenib—Hypertension—Hydrocortisone—asthma	7.88e-05	0.000341	CcSEcCtD
Dabrafenib—Haemoglobin—Prednisone—asthma	7.84e-05	0.000339	CcSEcCtD
Dabrafenib—Haemorrhage—Prednisone—asthma	7.8e-05	0.000337	CcSEcCtD
Dabrafenib—Erythema—Dexamethasone—asthma	7.8e-05	0.000337	CcSEcCtD
Dabrafenib—Erythema—Betamethasone—asthma	7.8e-05	0.000337	CcSEcCtD
Dabrafenib—Myalgia—Hydrocortisone—asthma	7.77e-05	0.000336	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	7.72e-05	0.000334	CcSEcCtD
Dabrafenib—Connective tissue disorder—Prednisone—asthma	7.67e-05	0.000332	CcSEcCtD
Dabrafenib—Nausea—Budesonide—asthma	7.65e-05	0.000331	CcSEcCtD
Dabrafenib—Oedema—Prednisolone—asthma	7.63e-05	0.00033	CcSEcCtD
Dabrafenib—Cough—Triamcinolone—asthma	7.5e-05	0.000324	CcSEcCtD
Dabrafenib—Oedema—Hydrocortisone—asthma	7.45e-05	0.000322	CcSEcCtD
Dabrafenib—Hypertension—Triamcinolone—asthma	7.42e-05	0.000321	CcSEcCtD
Dabrafenib—Hypertension—Methylprednisolone—asthma	7.41e-05	0.00032	CcSEcCtD
Dabrafenib—Infection—Hydrocortisone—asthma	7.4e-05	0.00032	CcSEcCtD
Dabrafenib—Hyperhidrosis—Prednisolone—asthma	7.38e-05	0.000319	CcSEcCtD
Dabrafenib—Myalgia—Triamcinolone—asthma	7.32e-05	0.000316	CcSEcCtD
Dabrafenib—Nervous system disorder—Hydrocortisone—asthma	7.31e-05	0.000316	CcSEcCtD
Dabrafenib—Myalgia—Methylprednisolone—asthma	7.3e-05	0.000316	CcSEcCtD
Dabrafenib—Arthralgia—Methylprednisolone—asthma	7.3e-05	0.000316	CcSEcCtD
Dabrafenib—Eye disorder—Prednisone—asthma	7.29e-05	0.000315	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	7.25e-05	0.000314	CcSEcCtD
Dabrafenib—Skin disorder—Hydrocortisone—asthma	7.24e-05	0.000313	CcSEcCtD
Dabrafenib—Hyperhidrosis—Hydrocortisone—asthma	7.2e-05	0.000311	CcSEcCtD
Dabrafenib—Dry mouth—Triamcinolone—asthma	7.16e-05	0.000309	CcSEcCtD
Dabrafenib—Angiopathy—Prednisone—asthma	7.08e-05	0.000306	CcSEcCtD
Dabrafenib—Immune system disorder—Prednisone—asthma	7.05e-05	0.000305	CcSEcCtD
Dabrafenib—Oedema—Triamcinolone—asthma	7.02e-05	0.000303	CcSEcCtD
Dabrafenib—Arrhythmia—Prednisone—asthma	6.97e-05	0.000301	CcSEcCtD
Dabrafenib—Infection—Triamcinolone—asthma	6.97e-05	0.000301	CcSEcCtD
Dabrafenib—Hypotension—Hydrocortisone—asthma	6.96e-05	0.000301	CcSEcCtD
Dabrafenib—Infection—Methylprednisolone—asthma	6.95e-05	0.000301	CcSEcCtD
Dabrafenib—Insomnia—Prednisolone—asthma	6.9e-05	0.000298	CcSEcCtD
Dabrafenib—Alopecia—Prednisone—asthma	6.9e-05	0.000298	CcSEcCtD
Dabrafenib—Nervous system disorder—Methylprednisolone—asthma	6.87e-05	0.000297	CcSEcCtD
Dabrafenib—Mental disorder—Prednisone—asthma	6.84e-05	0.000296	CcSEcCtD
Dabrafenib—Skin disorder—Methylprednisolone—asthma	6.8e-05	0.000294	CcSEcCtD
Dabrafenib—Erythema—Prednisone—asthma	6.79e-05	0.000294	CcSEcCtD
Dabrafenib—Malnutrition—Prednisone—asthma	6.79e-05	0.000294	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Hydrocortisone—asthma	6.79e-05	0.000294	CcSEcCtD
Dabrafenib—Hyperhidrosis—Triamcinolone—asthma	6.78e-05	0.000293	CcSEcCtD
Dabrafenib—Hyperhidrosis—Methylprednisolone—asthma	6.77e-05	0.000293	CcSEcCtD
Dabrafenib—Insomnia—Hydrocortisone—asthma	6.74e-05	0.000291	CcSEcCtD
Dabrafenib—Hypertension—Dexamethasone—asthma	6.73e-05	0.000291	CcSEcCtD
Dabrafenib—Hypertension—Betamethasone—asthma	6.73e-05	0.000291	CcSEcCtD
Dabrafenib—Myalgia—Dexamethasone—asthma	6.64e-05	0.000287	CcSEcCtD
Dabrafenib—Myalgia—Betamethasone—asthma	6.64e-05	0.000287	CcSEcCtD
Dabrafenib—Hypotension—Methylprednisolone—asthma	6.54e-05	0.000283	CcSEcCtD
Dabrafenib—Decreased appetite—Hydrocortisone—asthma	6.48e-05	0.00028	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Hydrocortisone—asthma	6.43e-05	0.000278	CcSEcCtD
Dabrafenib—Fatigue—Hydrocortisone—asthma	6.42e-05	0.000278	CcSEcCtD
Dabrafenib—Vision blurred—Prednisone—asthma	6.4e-05	0.000277	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Triamcinolone—asthma	6.39e-05	0.000276	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Methylprednisolone—asthma	6.38e-05	0.000276	CcSEcCtD
Dabrafenib—Oedema—Dexamethasone—asthma	6.37e-05	0.000275	CcSEcCtD
Dabrafenib—Oedema—Betamethasone—asthma	6.37e-05	0.000275	CcSEcCtD
Dabrafenib—Insomnia—Triamcinolone—asthma	6.35e-05	0.000274	CcSEcCtD
Dabrafenib—Insomnia—Methylprednisolone—asthma	6.33e-05	0.000274	CcSEcCtD
Dabrafenib—Infection—Betamethasone—asthma	6.32e-05	0.000273	CcSEcCtD
Dabrafenib—Infection—Dexamethasone—asthma	6.32e-05	0.000273	CcSEcCtD
Dabrafenib—Anaemia—Prednisone—asthma	6.28e-05	0.000271	CcSEcCtD
Dabrafenib—Nervous system disorder—Dexamethasone—asthma	6.24e-05	0.00027	CcSEcCtD
Dabrafenib—Nervous system disorder—Betamethasone—asthma	6.24e-05	0.00027	CcSEcCtD
Dabrafenib—Thrombocytopenia—Dexamethasone—asthma	6.23e-05	0.000269	CcSEcCtD
Dabrafenib—Thrombocytopenia—Betamethasone—asthma	6.23e-05	0.000269	CcSEcCtD
Dabrafenib—Hyperhidrosis—Dexamethasone—asthma	6.15e-05	0.000266	CcSEcCtD
Dabrafenib—Hyperhidrosis—Betamethasone—asthma	6.15e-05	0.000266	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Hydrocortisone—asthma	6.09e-05	0.000263	CcSEcCtD
Dabrafenib—Fatigue—Triamcinolone—asthma	6.05e-05	0.000262	CcSEcCtD
Dabrafenib—Fatigue—Methylprednisolone—asthma	6.04e-05	0.000261	CcSEcCtD
Dabrafenib—Hypotension—Dexamethasone—asthma	5.95e-05	0.000257	CcSEcCtD
Dabrafenib—Hypotension—Betamethasone—asthma	5.95e-05	0.000257	CcSEcCtD
Dabrafenib—Abdominal pain—Hydrocortisone—asthma	5.89e-05	0.000255	CcSEcCtD
Dabrafenib—Body temperature increased—Hydrocortisone—asthma	5.89e-05	0.000255	CcSEcCtD
Dabrafenib—Hypertension—Prednisone—asthma	5.86e-05	0.000254	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Betamethasone—asthma	5.8e-05	0.000251	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Dexamethasone—asthma	5.8e-05	0.000251	CcSEcCtD
Dabrafenib—Myalgia—Prednisone—asthma	5.78e-05	0.00025	CcSEcCtD
Dabrafenib—Arthralgia—Prednisone—asthma	5.78e-05	0.00025	CcSEcCtD
Dabrafenib—Insomnia—Betamethasone—asthma	5.76e-05	0.000249	CcSEcCtD
Dabrafenib—Insomnia—Dexamethasone—asthma	5.76e-05	0.000249	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	5.74e-05	0.000248	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Methylprednisolone—asthma	5.72e-05	0.000248	CcSEcCtD
Dabrafenib—Hypersensitivity—Prednisolone—asthma	5.62e-05	0.000243	CcSEcCtD
Dabrafenib—Body temperature increased—Triamcinolone—asthma	5.55e-05	0.00024	CcSEcCtD
Dabrafenib—Oedema—Prednisone—asthma	5.54e-05	0.00024	CcSEcCtD
Dabrafenib—Abdominal pain—Methylprednisolone—asthma	5.53e-05	0.000239	CcSEcCtD
Dabrafenib—Decreased appetite—Dexamethasone—asthma	5.53e-05	0.000239	CcSEcCtD
Dabrafenib—Decreased appetite—Betamethasone—asthma	5.53e-05	0.000239	CcSEcCtD
Dabrafenib—Infection—Prednisone—asthma	5.51e-05	0.000238	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Dexamethasone—asthma	5.5e-05	0.000238	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Betamethasone—asthma	5.5e-05	0.000238	CcSEcCtD
Dabrafenib—Hypersensitivity—Hydrocortisone—asthma	5.49e-05	0.000237	CcSEcCtD
Dabrafenib—Fatigue—Betamethasone—asthma	5.49e-05	0.000237	CcSEcCtD
Dabrafenib—Fatigue—Dexamethasone—asthma	5.49e-05	0.000237	CcSEcCtD
Dabrafenib—Nervous system disorder—Prednisone—asthma	5.44e-05	0.000235	CcSEcCtD
Dabrafenib—Skin disorder—Prednisone—asthma	5.39e-05	0.000233	CcSEcCtD
Dabrafenib—Hyperhidrosis—Prednisone—asthma	5.36e-05	0.000232	CcSEcCtD
Dabrafenib—Asthenia—Hydrocortisone—asthma	5.35e-05	0.000231	CcSEcCtD
Dabrafenib—Pruritus—Hydrocortisone—asthma	5.27e-05	0.000228	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Dexamethasone—asthma	5.21e-05	0.000225	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Betamethasone—asthma	5.21e-05	0.000225	CcSEcCtD
Dabrafenib—Hypersensitivity—Triamcinolone—asthma	5.17e-05	0.000223	CcSEcCtD
Dabrafenib—Hypersensitivity—Methylprednisolone—asthma	5.16e-05	0.000223	CcSEcCtD
Dabrafenib—Diarrhoea—Hydrocortisone—asthma	5.1e-05	0.00022	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Prednisone—asthma	5.05e-05	0.000218	CcSEcCtD
Dabrafenib—Dizziness—Prednisolone—asthma	5.05e-05	0.000218	CcSEcCtD
Dabrafenib—Asthenia—Triamcinolone—asthma	5.03e-05	0.000218	CcSEcCtD
Dabrafenib—Body temperature increased—Betamethasone—asthma	5.03e-05	0.000218	CcSEcCtD
Dabrafenib—Body temperature increased—Dexamethasone—asthma	5.03e-05	0.000218	CcSEcCtD
Dabrafenib—Abdominal pain—Betamethasone—asthma	5.03e-05	0.000218	CcSEcCtD
Dabrafenib—Abdominal pain—Dexamethasone—asthma	5.03e-05	0.000218	CcSEcCtD
Dabrafenib—Asthenia—Methylprednisolone—asthma	5.02e-05	0.000217	CcSEcCtD
Dabrafenib—Insomnia—Prednisone—asthma	5.01e-05	0.000217	CcSEcCtD
Dabrafenib—Pruritus—Triamcinolone—asthma	4.96e-05	0.000215	CcSEcCtD
Dabrafenib—Pruritus—Methylprednisolone—asthma	4.95e-05	0.000214	CcSEcCtD
Dabrafenib—Dizziness—Hydrocortisone—asthma	4.93e-05	0.000213	CcSEcCtD
Dabrafenib—Decreased appetite—Prednisone—asthma	4.82e-05	0.000208	CcSEcCtD
Dabrafenib—Rash—Prednisolone—asthma	4.81e-05	0.000208	CcSEcCtD
Dabrafenib—Dermatitis—Prednisolone—asthma	4.81e-05	0.000208	CcSEcCtD
Dabrafenib—Diarrhoea—Methylprednisolone—asthma	4.79e-05	0.000207	CcSEcCtD
Dabrafenib—Fatigue—Prednisone—asthma	4.78e-05	0.000207	CcSEcCtD
Dabrafenib—Headache—Prednisolone—asthma	4.78e-05	0.000207	CcSEcCtD
Dabrafenib—Constipation—Prednisone—asthma	4.74e-05	0.000205	CcSEcCtD
Dabrafenib—Vomiting—Hydrocortisone—asthma	4.74e-05	0.000205	CcSEcCtD
Dabrafenib—Rash—Hydrocortisone—asthma	4.7e-05	0.000203	CcSEcCtD
Dabrafenib—Dermatitis—Hydrocortisone—asthma	4.69e-05	0.000203	CcSEcCtD
Dabrafenib—Headache—Hydrocortisone—asthma	4.67e-05	0.000202	CcSEcCtD
Dabrafenib—Dizziness—Triamcinolone—asthma	4.64e-05	0.000201	CcSEcCtD
Dabrafenib—Dizziness—Methylprednisolone—asthma	4.63e-05	0.0002	CcSEcCtD
Dabrafenib—Asthenia—Dexamethasone—asthma	4.57e-05	0.000197	CcSEcCtD
Dabrafenib—Asthenia—Betamethasone—asthma	4.57e-05	0.000197	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Prednisone—asthma	4.53e-05	0.000196	CcSEcCtD
Dabrafenib—Nausea—Prednisolone—asthma	4.53e-05	0.000196	CcSEcCtD
Dabrafenib—Pruritus—Betamethasone—asthma	4.5e-05	0.000195	CcSEcCtD
Dabrafenib—Pruritus—Dexamethasone—asthma	4.5e-05	0.000195	CcSEcCtD
Dabrafenib—Vomiting—Triamcinolone—asthma	4.46e-05	0.000193	CcSEcCtD
Dabrafenib—Vomiting—Methylprednisolone—asthma	4.45e-05	0.000192	CcSEcCtD
Dabrafenib—Nausea—Hydrocortisone—asthma	4.43e-05	0.000191	CcSEcCtD
Dabrafenib—Rash—Triamcinolone—asthma	4.42e-05	0.000191	CcSEcCtD
Dabrafenib—Dermatitis—Triamcinolone—asthma	4.42e-05	0.000191	CcSEcCtD
Dabrafenib—Rash—Methylprednisolone—asthma	4.41e-05	0.000191	CcSEcCtD
Dabrafenib—Dermatitis—Methylprednisolone—asthma	4.41e-05	0.000191	CcSEcCtD
Dabrafenib—Headache—Triamcinolone—asthma	4.4e-05	0.00019	CcSEcCtD
Dabrafenib—Headache—Methylprednisolone—asthma	4.39e-05	0.00019	CcSEcCtD
Dabrafenib—Abdominal pain—Prednisone—asthma	4.38e-05	0.000189	CcSEcCtD
Dabrafenib—Body temperature increased—Prednisone—asthma	4.38e-05	0.000189	CcSEcCtD
Dabrafenib—Diarrhoea—Betamethasone—asthma	4.36e-05	0.000188	CcSEcCtD
Dabrafenib—Diarrhoea—Dexamethasone—asthma	4.36e-05	0.000188	CcSEcCtD
Dabrafenib—Dizziness—Betamethasone—asthma	4.21e-05	0.000182	CcSEcCtD
Dabrafenib—Dizziness—Dexamethasone—asthma	4.21e-05	0.000182	CcSEcCtD
Dabrafenib—Nausea—Triamcinolone—asthma	4.17e-05	0.00018	CcSEcCtD
Dabrafenib—Nausea—Methylprednisolone—asthma	4.16e-05	0.00018	CcSEcCtD
Dabrafenib—Hypersensitivity—Prednisone—asthma	4.08e-05	0.000177	CcSEcCtD
Dabrafenib—Vomiting—Betamethasone—asthma	4.05e-05	0.000175	CcSEcCtD
Dabrafenib—Vomiting—Dexamethasone—asthma	4.05e-05	0.000175	CcSEcCtD
Dabrafenib—Rash—Dexamethasone—asthma	4.01e-05	0.000174	CcSEcCtD
Dabrafenib—Rash—Betamethasone—asthma	4.01e-05	0.000174	CcSEcCtD
Dabrafenib—Dermatitis—Dexamethasone—asthma	4.01e-05	0.000173	CcSEcCtD
Dabrafenib—Dermatitis—Betamethasone—asthma	4.01e-05	0.000173	CcSEcCtD
Dabrafenib—Headache—Betamethasone—asthma	3.99e-05	0.000172	CcSEcCtD
Dabrafenib—Headache—Dexamethasone—asthma	3.99e-05	0.000172	CcSEcCtD
Dabrafenib—Asthenia—Prednisone—asthma	3.98e-05	0.000172	CcSEcCtD
Dabrafenib—Pruritus—Prednisone—asthma	3.92e-05	0.00017	CcSEcCtD
Dabrafenib—Diarrhoea—Prednisone—asthma	3.79e-05	0.000164	CcSEcCtD
Dabrafenib—Nausea—Dexamethasone—asthma	3.78e-05	0.000163	CcSEcCtD
Dabrafenib—Nausea—Betamethasone—asthma	3.78e-05	0.000163	CcSEcCtD
Dabrafenib—Dizziness—Prednisone—asthma	3.67e-05	0.000159	CcSEcCtD
Dabrafenib—Vomiting—Prednisone—asthma	3.53e-05	0.000152	CcSEcCtD
Dabrafenib—Rash—Prednisone—asthma	3.5e-05	0.000151	CcSEcCtD
Dabrafenib—Dermatitis—Prednisone—asthma	3.49e-05	0.000151	CcSEcCtD
Dabrafenib—Headache—Prednisone—asthma	3.47e-05	0.00015	CcSEcCtD
Dabrafenib—Nausea—Prednisone—asthma	3.29e-05	0.000142	CcSEcCtD
Dabrafenib—SLCO1B1—Metabolism—ADCY2—asthma	1.32e-05	0.000101	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—POMC—asthma	1.32e-05	0.000101	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ALB—asthma	1.32e-05	0.000101	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—IL6—asthma	1.31e-05	0.0001	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CSF2—asthma	1.31e-05	0.0001	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.31e-05	0.0001	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PPP2CA—asthma	1.31e-05	0.0001	CbGpPWpGaD
Dabrafenib—BRAF—Disease—IL6R—asthma	1.31e-05	9.99e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CYBA—asthma	1.28e-05	9.81e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SMAD3—asthma	1.28e-05	9.77e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL2RA—asthma	1.27e-05	9.68e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SMAD3—asthma	1.26e-05	9.65e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALOX15—asthma	1.26e-05	9.64e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALOX5AP—asthma	1.26e-05	9.64e-05	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL6—asthma	1.26e-05	9.64e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL5—asthma	1.26e-05	9.6e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PARP1—asthma	1.26e-05	9.6e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—C3—asthma	1.26e-05	9.6e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—NQO1—asthma	1.25e-05	9.55e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LTC4S—asthma	1.24e-05	9.51e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	1.24e-05	9.45e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—VEGFA—asthma	1.23e-05	9.37e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—SERPINE1—asthma	1.22e-05	9.35e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ADCY2—asthma	1.22e-05	9.35e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PPP2CA—asthma	1.22e-05	9.34e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PDGFB—asthma	1.22e-05	9.34e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—STAT3—asthma	1.21e-05	9.28e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—BDKRB2—asthma	1.21e-05	9.26e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PPP2CA—asthma	1.21e-05	9.23e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CHAT—asthma	1.2e-05	9.2e-05	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—VEGFA—asthma	1.2e-05	9.2e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCR5—asthma	1.2e-05	9.18e-05	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—PTEN—asthma	1.2e-05	9.17e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CRP—asthma	1.19e-05	9.13e-05	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—IL6—asthma	1.19e-05	9.08e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—HMOX1—asthma	1.19e-05	9.07e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CCR5—asthma	1.19e-05	9.07e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL2RA—asthma	1.18e-05	9.04e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—RHOA—asthma	1.18e-05	9.02e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—C3—asthma	1.17e-05	8.97e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ADCY2—asthma	1.17e-05	8.96e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL3—asthma	1.17e-05	8.93e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—NOS3—asthma	1.17e-05	8.93e-05	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—PTEN—asthma	1.15e-05	8.8e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—TLR4—asthma	1.15e-05	8.75e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-DRB1—asthma	1.14e-05	8.74e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—asthma	1.14e-05	8.73e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PDGFB—asthma	1.14e-05	8.73e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	1.14e-05	8.68e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PDGFB—asthma	1.13e-05	8.62e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GSTP1—asthma	1.13e-05	8.61e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TGFB1—asthma	1.13e-05	8.6e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	1.11e-05	8.51e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—HMOX1—asthma	1.11e-05	8.49e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ITPR1—asthma	1.11e-05	8.47e-05	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TGFB1—asthma	1.1e-05	8.44e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—EGFR—asthma	1.1e-05	8.44e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—KNG1—asthma	1.1e-05	8.43e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALOX15—asthma	1.1e-05	8.4e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALOX5AP—asthma	1.1e-05	8.4e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—POMC—asthma	1.1e-05	8.4e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ICAM1—asthma	1.1e-05	8.39e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—AGTR1—asthma	1.1e-05	8.38e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CAT—asthma	1.1e-05	8.37e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—LEP—asthma	1.09e-05	8.35e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—POMC—asthma	1.09e-05	8.32e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LTA4H—asthma	1.08e-05	8.24e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—CD4—asthma	1.08e-05	8.23e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CCL2—asthma	1.08e-05	8.22e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALOX5—asthma	1.07e-05	8.2e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IL6R—asthma	1.07e-05	8.19e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCL10—asthma	1.07e-05	8.19e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PTGS2—asthma	1.07e-05	8.17e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	1.06e-05	8.1e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TNF—asthma	1.05e-05	8.03e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NTRK1—asthma	1.05e-05	8.03e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CHAT—asthma	1.05e-05	8.02e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GSTP1—asthma	1.04e-05	7.97e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ADRB2—asthma	1.04e-05	7.95e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GSTM1—asthma	1.03e-05	7.91e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PLA2G4A—asthma	1.03e-05	7.91e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—FN1—asthma	1.03e-05	7.87e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—HMOX1—asthma	1.03e-05	7.86e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ITPR1—asthma	1.03e-05	7.84e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CARM1—asthma	1.02e-05	7.82e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CAT—asthma	1.01e-05	7.75e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—DCN—asthma	1.01e-05	7.71e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NOS2—asthma	1.01e-05	7.69e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ALB—asthma	9.92e-06	7.58e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ITPR1—asthma	9.84e-06	7.52e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALDH2—asthma	9.81e-06	7.5e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL6R—asthma	9.8e-06	7.49e-05	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—EGFR—asthma	9.75e-06	7.45e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—RHOA—asthma	9.68e-06	7.4e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GSTM1—asthma	9.58e-06	7.32e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PLA2G4A—asthma	9.58e-06	7.32e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PPP2CA—asthma	9.53e-06	7.28e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—NOS3—asthma	9.49e-06	7.26e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—asthma	9.44e-06	7.21e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ARG1—asthma	9.43e-06	7.21e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—POMC—asthma	9.38e-06	7.17e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CD86—asthma	9.37e-06	7.16e-05	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—EGFR—asthma	9.36e-06	7.15e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALOX5—asthma	9.35e-06	7.14e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GSTT1—asthma	9.34e-06	7.13e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PTEN—asthma	9.32e-06	7.12e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—EDN1—asthma	9.29e-06	7.1e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL5—asthma	9.22e-06	7.05e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PLA2G4A—asthma	9.19e-06	7.02e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCL2—asthma	9.18e-06	7.02e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL6R—asthma	9.15e-06	7e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CSF2—asthma	9.08e-06	6.94e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IL6R—asthma	9.04e-06	6.91e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CARM1—asthma	8.92e-06	6.82e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SMAD3—asthma	8.84e-06	6.76e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PPP2CA—asthma	8.82e-06	6.74e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—DCN—asthma	8.79e-06	6.72e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTGS2—asthma	8.68e-06	6.64e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—asthma	8.6e-06	6.58e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SERPINE1—asthma	8.57e-06	6.55e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALDH2—asthma	8.55e-06	6.53e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALDH7A1—asthma	8.53e-06	6.52e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CXCL8—asthma	8.5e-06	6.5e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—IL6—asthma	8.48e-06	6.48e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SERPINE1—asthma	8.47e-06	6.47e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PPP2CA—asthma	8.46e-06	6.46e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—BCL2—asthma	8.43e-06	6.44e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IFNG—asthma	8.35e-06	6.38e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—STAT3—asthma	8.34e-06	6.37e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCR5—asthma	8.31e-06	6.35e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—RHOA—asthma	8.27e-06	6.32e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL2RA—asthma	8.19e-06	6.26e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NOS3—asthma	8.18e-06	6.25e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ARG2—asthma	8.17e-06	6.25e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—RHOA—asthma	8.17e-06	6.24e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GSTT1—asthma	8.13e-06	6.22e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IL2—asthma	8.12e-06	6.21e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—C3—asthma	8.12e-06	6.2e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NOS3—asthma	8.09e-06	6.18e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD4—asthma	8.07e-06	6.17e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PDGFB—asthma	7.9e-06	6.04e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—NQO1—asthma	7.76e-06	5.93e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TGFB1—asthma	7.73e-06	5.91e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ADCY2—asthma	7.59e-06	5.8e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—EGFR—asthma	7.58e-06	5.79e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTEN—asthma	7.57e-06	5.79e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—LEP—asthma	7.56e-06	5.78e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—asthma	7.53e-06	5.75e-05	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—IL6—asthma	7.49e-06	5.73e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1B—asthma	7.45e-06	5.69e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CD4—asthma	7.45e-06	5.69e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL2—asthma	7.42e-06	5.67e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTGS2—asthma	7.39e-06	5.65e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—POMC—asthma	7.31e-06	5.59e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCL8—asthma	7.26e-06	5.55e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ALB—asthma	7.13e-06	5.45e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FN1—asthma	7.13e-06	5.45e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PTEN—asthma	6.98e-06	5.34e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL2—asthma	6.94e-06	5.3e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALOX15—asthma	6.77e-06	5.18e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALOX5AP—asthma	6.77e-06	5.18e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—POMC—asthma	6.77e-06	5.18e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—NQO1—asthma	6.76e-06	5.17e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ALB—asthma	6.67e-06	5.1e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ADCY2—asthma	6.61e-06	5.05e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MMP9—asthma	6.57e-06	5.02e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	6.56e-06	5.02e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PTEN—asthma	6.53e-06	4.99e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—POMC—asthma	6.49e-06	4.96e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GSTP1—asthma	6.47e-06	4.95e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CHAT—asthma	6.46e-06	4.94e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTEN—asthma	6.45e-06	4.93e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—HMOX1—asthma	6.38e-06	4.88e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—NOS3—asthma	6.38e-06	4.87e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ITPR1—asthma	6.37e-06	4.87e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL2—asthma	6.35e-06	4.85e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL6R—asthma	6.33e-06	4.84e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CAT—asthma	6.3e-06	4.81e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—STAT3—asthma	6.25e-06	4.77e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—EGFR—asthma	6.21e-06	4.75e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ALB—asthma	6.17e-06	4.72e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PLA2G4A—asthma	5.95e-06	4.54e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GSTM1—asthma	5.95e-06	4.54e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SERPINE1—asthma	5.93e-06	4.53e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—NOS3—asthma	5.91e-06	4.51e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—VEGFA—asthma	5.9e-06	4.51e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—STAT3—asthma	5.84e-06	4.46e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGS2—asthma	5.83e-06	4.46e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—IL6—asthma	5.82e-06	4.45e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—STAT3—asthma	5.77e-06	4.41e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALOX5—asthma	5.76e-06	4.4e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RHOA—asthma	5.72e-06	4.37e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—EGFR—asthma	5.68e-06	4.34e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NOS3—asthma	5.66e-06	4.33e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GSTP1—asthma	5.64e-06	4.31e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—HMOX1—asthma	5.56e-06	4.25e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ITPR1—asthma	5.55e-06	4.24e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CARM1—asthma	5.49e-06	4.2e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CAT—asthma	5.49e-06	4.19e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PPP2CA—asthma	5.48e-06	4.19e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—DCN—asthma	5.42e-06	4.14e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TGFB1—asthma	5.41e-06	4.14e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGS2—asthma	5.4e-06	4.13e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TGFB1—asthma	5.35e-06	4.09e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—EGFR—asthma	5.31e-06	4.05e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALDH2—asthma	5.27e-06	4.03e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—EGFR—asthma	5.24e-06	4.01e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PLA2G4A—asthma	5.18e-06	3.96e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GSTM1—asthma	5.18e-06	3.96e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTEN—asthma	5.09e-06	3.89e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCL8—asthma	5.02e-06	3.84e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GSTT1—asthma	5.01e-06	3.83e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL2—asthma	4.8e-06	3.67e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IL6—asthma	4.78e-06	3.65e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PPP2CA—asthma	4.77e-06	3.65e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTEN—asthma	4.71e-06	3.6e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MMP9—asthma	4.54e-06	3.47e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PTEN—asthma	4.52e-06	3.45e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL6—asthma	4.36e-06	3.33e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—POMC—asthma	4.2e-06	3.21e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—NQO1—asthma	4.16e-06	3.18e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—VEGFA—asthma	4.08e-06	3.12e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL6—asthma	4.08e-06	3.12e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADCY2—asthma	4.08e-06	3.11e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—STAT3—asthma	4.04e-06	3.09e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IL6—asthma	4.03e-06	3.08e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALB—asthma	3.83e-06	2.93e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TGFB1—asthma	3.74e-06	2.86e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—EGFR—asthma	3.67e-06	2.81e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—NOS3—asthma	3.67e-06	2.8e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—POMC—asthma	3.66e-06	2.8e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GSTP1—asthma	3.47e-06	2.65e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HMOX1—asthma	3.43e-06	2.62e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ITPR1—asthma	3.42e-06	2.61e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CAT—asthma	3.38e-06	2.58e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGS2—asthma	3.35e-06	2.56e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALB—asthma	3.34e-06	2.55e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—NOS3—asthma	3.19e-06	2.44e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PLA2G4A—asthma	3.19e-06	2.44e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GSTM1—asthma	3.19e-06	2.44e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PPP2CA—asthma	2.94e-06	2.25e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTEN—asthma	2.92e-06	2.23e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGS2—asthma	2.92e-06	2.23e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL6—asthma	2.82e-06	2.16e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTEN—asthma	2.55e-06	1.95e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—POMC—asthma	2.26e-06	1.72e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALB—asthma	2.06e-06	1.57e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—NOS3—asthma	1.97e-06	1.5e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS2—asthma	1.8e-06	1.38e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTEN—asthma	1.57e-06	1.2e-05	CbGpPWpGaD
